Sitravatinib Plus Pembrolizumab in Patients With Advanced Treatment-Naïve PD-L1+ Non-Squamous NSCLC
- First Posted Date
- 2021-06-14
- Last Posted Date
- 2024-01-30
- Lead Sponsor
- Sarah Goldberg
- Target Recruit Count
- 9
- Registration Number
- NCT04925986
- Locations
- 🇺🇸
Yale University, New Haven, Connecticut, United States
© Copyright 2024. All Rights Reserved by MedPath